Matrix metalloproteinase 2 as a pharmacological target in heart failure

PR Gonçalves, LD Nascimento, RF Gerlach… - Pharmaceuticals, 2022 - mdpi.com
Heart failure (HF) is an acute or chronic clinical syndrome that results in a decrease in
cardiac output and an increase in intracardiac pressure at rest or upon exertion. The …

Matrix metalloproteinases and arterial hypertension: role of oxidative stress and nitric oxide in vascular functional and structural alterations

AF Prado, RIM Batista, JE Tanus-Santos, RF Gerlach - Biomolecules, 2021 - mdpi.com
Various pathophysiological mechanisms have been implicated in hypertension, but those
resulting in vascular dysfunction and remodeling are critical and may help to identify critical …

Matrix metalloproteinase 2 as a potential mediator of vascular smooth muscle cell migration and chronic vascular remodeling in hypertension

VA Belo, DA Guimarães, MM Castro - Journal of vascular research, 2016 - karger.com
For vascular remodeling in hypertension, it is essential that vascular smooth muscle cells
(VSMCs) reshape in order to proliferate and migrate. The extracellular matrix (ECM) needs …

Arterial stiffness and stroke: de-stiffening strategy, a therapeutic target for stroke

Y Chen, F Shen, J Liu, GY Yang - Stroke and vascular Neurology, 2017 - svn.bmj.com
Stroke is the second leading cause of mortality and morbidity worldwide. Early intervention
is of great importance in reducing disease burden. Since the conventional risk factors cannot …

Matrix metalloproteinases are involved in cardiovascular diseases

A Azevedo, AF Prado, RC Antonio… - Basic & Clinical …, 2014 - Wiley Online Library
This MiniReview describes the essential biochemical and molecular aspects of matrix
metalloproteinases (MMP s) and briefly discusses how they engage in different diseases …

Circulating matrix metalloproteinases and their inhibitors in hypertension

V Fontana, PS Silva, RF Gerlach, JE Tanus-Santos - Clinica Chimica Acta, 2012 - Elsevier
Growing experimental evidence indicates that matrix metalloproteinases (MMPs) are
implicated in many cardiovascular diseases including hypertension and its chronic …

[HTML][HTML] Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension

MM Castro, JE Tanus-Santos, RF Gerlach - Pharmacological research, 2011 - Elsevier
Hypertension is associated with well known structural and functional alterations in both
resistance and conduit arteries, which may be the result from long-lasting high blood …

Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension

MMB de Mello, JM Parente, R Schulz, MM Castro - Vascular pharmacology, 2019 - Elsevier
Hypertension is characterized by maladaptive vascular remodeling and enhanced oxidative
stress in the vascular wall. Peroxynitrite may directly activate latent matrix metalloproteinase …

Matrix metalloproteinases as drug targets in preeclampsia

A CT Palei, J P. Granger… - Current drug targets, 2013 - benthamdirect.com
Preeclampsia is an important syndrome complicating pregnancy. While the pathogenesis of
preeclampsia is not entirely known, poor placental perfusion leading to widespread …

Inhibition of matrix metalloproteinases (MMPs) as a potential strategy to ameliorate hypertension-induced cardiovascular alterations

MM Castro, JE Tanus-Santos - Current drug targets, 2013 - ingentaconnect.com
A group of proteases, the matrix metalloproteinases (MMPs) are well known for their
capacity to degrade extracellular matrix (ECM) proteins. Particularly MMP-2 and MMP-9 …